Bespoke Extracts (BSPK) CEO Michael Feinsod reports 2.52M share stake
Rhea-AI Filing Summary
Bespoke Extracts, Inc. insider Michael Feinsod, who serves as chief executive officer, director, and a 10% owner, filed an annual statement of changes in beneficial ownership. The filing reports two acquisitions of common stock in 2025: 1,500 shares on 09/24/2025 at $0.27 per share and 1,000 shares on 12/19/2025 at $0.20 per share. Following these transactions, Feinsod beneficially owned 2,516,112 shares of common stock at the end of the fiscal year. Of this amount, 1,501,000 shares are held directly by Feinsod and 1,015,112 shares are held by Infinity Management, LLC, where he is the managing member.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,000 | $0.20 | $200.00 |
| Grant/Award | Common Stock | 1,500 | $0.27 | $405.00 |
Footnotes (1)
- [object Object]
FAQ
What did Michael Feinsod report in this Form 5 for Bespoke Extracts (BSPK)?
Michael Feinsod reported annual changes in his beneficial ownership of Bespoke Extracts, Inc. common stock, including two acquisitions in 2025 and his total holdings of 2,516,112 shares at year-end.
What is Michael Feinsod’s total beneficial ownership in Bespoke Extracts (BSPK) after these transactions?
After the reported transactions, Feinsod beneficially owned 2,516,112 Bespoke Extracts common shares at the end of the fiscal year.
What roles does Michael Feinsod hold at Bespoke Extracts (BSPK)?
Feinsod is identified as a director, a chief executive officer, and a 10% owner of Bespoke Extracts, Inc.
Were any derivative securities reported for Michael Feinsod in this Bespoke Extracts (BSPK) Form 5?
No derivative securities (such as options or warrants) are listed in Table II; the report only shows non-derivative common stock transactions and holdings.